A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|14|3|236-246

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.14, Iss.3, 2014-06, pp. : 236-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-01 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Infective and Anti-Tumor Agents Based on the Depletion of Immune Suppressive Effects

By  

Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. : 991-996

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn’s Disease

By Shetty A.   Forbes A.  

American Journal of PharmacoGenomics, Vol. 2, Iss. 4, 2002-01 ,pp. : 215-221

Adis International

Access to resources Recommend Favorite

Anti-Cancer / Anti-Tumor

By  

Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. : 1-24

Bentham Science Publishers

Access to resources Recommend Favorite

Carcinoembryonic Antigen as a Target to Induce Anti-Tumor Immune Responses

By  

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 443-454

Bentham Science Publishers

Access to resources Recommend Favorite